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ABSTRACT 
Processing of amyloid precursor protein by β- and γ-secretase to form fragments of 
amyloid β (Aβ) which aggregate into extracellular plaques is thought to be a key 
pathological process in the development of Alzheimer’s disease (AD). Little is known 
about the mechanism behind the disequilibrium of production and clearance of Aβ in 
sporadic cases of AD. Animal and human studies have implicated hypoxia as a factor 
behind increased production of Aβ, the relevance of this is supported by the frequent 
comorbidity of AD and vascular dementia. The development of highly sensitive 
assays enables analysis of neurochemical markers in blood instead of in cerebrospinal 
fluid. This opens a window of discovery into brief and dynamic physiological 
processes of the brain, previously beyond reach. In the current paper we studied 
effects of transient hypoxia on amyloid metabolism and neuronal damage in human 
subjects. Sixteen divers competing in the national Swedish championship in breath-
hold diving were enrolled. Blood was sampled at baseline and after each of three 
competitions and analyzed for markers of amyloid metabolism (Aβ42) and neuronal 
damage (T-tau, NFL, S100β). During the first competition, divers held their breath for 
a median of five minutes and we saw increased Aβ42 (p = 0.0006) and T-tau (p = 
0.001) compared to baseline. The levels of T-tau correlated with the length of the 
apneic time during two of the competitions. We conclude that transient hypoxia in 
healthy adults may stimulate Aβ production, with implications in AD molecular 
pathogenesis, and cause mild transitory neuronal dysfunction or damage. 
 
INTRODUCTION 
Processing of amyloid precursor protein by β- and γ-secretase to form amyloid β (Aβ) 
that aggregates into insoluble extracellular plaques is thought to be a key pathological 
process in the development of Alzheimer’s disease (AD) (3). Little is known about 
the mechanism behind the disequilibrium of production and clearance of Aβ in 
sporadic cases of AD (3). Both animal (21) and human (8, 15, 25) studies have 
implicated hypoxia as a factor leading to increased production of Aβ. The relevance 
of this is supported by the frequent comorbidity of AD and vascular dementia (10, 
16), as well as the observation that those afflicted by sleep-disordered breathing run a 
higher risk of developing dementia (2, 14, 24). Further, Aβ appears to be a potent 
vasoconstrictor and accumulates in vessel walls, and its overabundance could have a 
discordant effect on the cerebral circulation (1, 13, 22). Development of highly 
sensitive assays capable of detecting proteins at subfemtomolar levels of 
concentration allow for analysis of brain derived proteins in blood instead of in 
cerebrospinal fluid (18). This opens a window of discovery into brief and dynamic 
physiological processes of the brain, previously beyond reach.  
 
 
Static apnea and dynamic apnea with or without fins are disciplines of breath-hold 
diving in the sport of freediving. Divers are timed while holding their breath and 
remaining motionless, static, or while trying to swim, dynamic, as far as they can 
underwater. 
 
Studies have confirmed the intuition that holding one’s breath will decrease oxygen 
saturation (SaO2) in a time-dependent fashion, and that trained divers are able to 
lower their SaO2 further compared with untrained individuals (5). In addition, oxygen 
consumption and thus decrease in SaO2 is more pronounced during physical exercise 
compared with rest (4). Therefore, subjects trained in breath-hold diving present an 
interesting opportunity to study the effect of hypoxia on various physiological 
systems.  
 
In the present study, we test the hypothesis that hypoxia during breath-hold diving 
may affect blood biomarkers reflecting amyloid metabolism and structural brain 
injury. 
METHODS 
Ethical approval & consent 
The study was approved by the ethics committee at the University of Gothenburg and 
written informed consent was obtained from all participants. 
 
Study population 
Sixteen subjects (14 male, 2 female, median [range] 36 [16-51] years old) 
participating in the national Swedish championship in breath-hold diving were 
included. Five age and gender matched subjects (4 male, 1 female, 32 [27-38] years 
old) volunteered as controls (C) (Table 1). 
 
Execution 
The divers and the matched healthy controls were sampled for baseline (B) values 
approximately 3 hours prior to the start of competitions. Divers were then sampled 
after the first competition (static apnea, STA), following the remaining competitions 
after an additional 21 hours (dynamic apnea without fins, DYN1) and finally after an 
additional 16 hours (dynamic apnea with fins, DYN2). Samples were collected within 
an hour of the competitions ending. 
 
Biochemical analyses 
Blood samples were collected by peripheral venipuncture in gel-separator tubes for 
serum and EDTA tubes for plasma. Samples were centrifuged within 20 to 60 minutes 
and then aliquoted and stored at -80°C.  
 
S-100β was analyzed in serum on a Modular E170 instrument (Roche Diagnostics, 
Basel, Switzerland) with reagents from the same manufacturer. Plasma T-tau and 
Aβ42 were measured using immunoassay digital array technology (Quanterix Corp, 
Boston, MA, USA) as described previously (12, 18). Serum NFL levels were 
determined using the NF-Light kit from UmanDiagnostics (UmanDiagnostics, Umeå, 
Sweden), transferred onto the Simoa platform using a homebrew kit (Quanterix Corp, 
Boston, MA, USA). The lower limits of quantification were 5 pg/mL for S-100β, 
0.007 pg/mL for T-tau, 0.032 pg/mL for Aβ42 and 0.26 pg/mL for NFL. Intra-assay 
coefficients of variation were 3.1% for S-100β and 5-10% for T-tau, Aβ42 and NFL.  
 
All samples were analyzed at the same time using the same batch of reagents by 
board-certified laboratory technicians who were blinded to clinical information. 
 
Statistical analyses 
For comparison of biomarker levels after competition versus their baseline levels or 
the control group, the Mann-Whitney U-test (unpaired analyses) or the Wilcoxon 
matched-pairs signed rank test (paired analyses) was used. The Spearman’s rank 
correlation coefficient (rho, ) was used for analyses of correlation between changes 
in various biomarker levels after competition and breath-holding time. Statistical 
significance was determined at P < 0.05. All statistical calculations were performed 
using GraphPad Prism version 6.05 (GraphPad Inc., San Diego, California).  
 RESULTS 
Biomarker reflecting amyloid metabolism 
There was no difference in the plasma level of Aβ42 between the divers at baseline 
and the control group (Table 1). Comparing divers’ baseline vs. STA biomarker 
results, there was a significant increase in the levels of Aβ42 after the first event of 
static apnea (p = 0.0006, Figure 1). However, there was no significant change in the 
levels of Aβ42 when comparing divers’ baseline vs. the DYN1 and DYN2 time points 
(Figure 1). Aβ42 did not correlate to the length of apneic time (Figure 2A).  
 
Biomarkers reflecting structural brain injury 
Divers had significantly higher baseline T-tau than controls (p = 0.04, Table 1). 
Comparing divers’ baseline vs. STA biomarker results, we found a significant 
increase in the levels of T-tau after the first competition (p = 0.001) and a significant 
decrease after one of the dynamic events, DYN2 (p = 0.03, Figure 1). Further, T-tau 
correlated with the length of apneic time during STA (ρ = 0.72, p = 0.004) and during 
DYN1 (ρ = 0.66, p = 0.01) but not during DYN2 (ρ = 0.42, p = 0.14, Figure 2D). 
There were no significant changes in the levels of serum NFL and S-100β between 
competition events (Figure 1). Also, the levels of NFL and S100β did not correlate 
with apneic time (Figure 2B-C).   
 
 
DISCUSSION 
The first finding was that plasma levels of Aβ42 increased following the transient 
hypoxia induced by breath-hold diving. Divers held their breath longer during STA 
compared with DYN1 or DYN2 (Table 1), which may have resulted in a more severe 
hypoxia and thus explain why the rise of Aβ42 was only seen during STA. As 
expected, the magnitude of the rise was much smaller than what we have previously 
seen after the severe failure of cerebral circulation during cardiac arrest (17, 25). After 
ischemic damage or severe traumatic brain injury, a significant portion of the efflux 
of brain-derived proteins likely occur across a damaged, leaky blood-brain barrier 
(BBB) (11). Transient hypoxia only partially mimics the physiological disruption 
induced by global cerebral ischemia and the absence of a concomitant increase of 
S100β and NFL in our study makes BBB damage less likely to explain the increase of 
Aβ42. Another potential explanation to the increase of Aβ42 may be that we 
unknowingly measured Aβ42 derived from peripheral tissues. However this is less 
likely considering the absence of increase after DYN1 and DYN2, during which the 
stress on peripheral tissues was arguably greater. It is also necessary to consider how 
Aβ42 reaches the circulation rapidly in the absence of evident BBB disruption. It is 
possible that the translocation of Aβ42 from brain interstitial fluid to blood occurs 
through the recently described glymphatic system, which enables a rapid turnover of 
the brain extracellular fluid and its contents (9).  
 
We suggest that our findings indicate an increased amyloidogenic processing of APP 
as a result of transient hypoxia, which might have implications in AD molecular 
pathogenesis and resonates well with epidemiological studies showing an association 
between sleep-disordered breathing and dementia (2, 14, 24). 
 
 
The second finding was that levels of T-tau increased after STA (to 196% of baseline 
levels) and that T-tau correlated to apneic time during STA and DYN1. T-tau is 
predominantly expressed in unmyelinated cortical axons, abundant in the central 
nervous system and less common elsewhere (23). The implication is that transient 
hypoxia may result in mild cortical neuronal dysfunction or injury. It is interesting 
that this occurs below the physiological breaking point of drawing breath, i.e. before 
the prolonged hypoxia results in a forced breath. While we studied divers trained in 
breath-hold diving, a similar physiological situation may regularly occur in subjects 
afflicted by sleep-disordered breathing.  
 
T-tau decreased after DYN2 compared to baseline values, however the statistical 
significance of this was weak compared to our other findings (p = 0.03) and 
additionally the diver baseline T-tau was already slightly elevated compared to 
controls (p = 0.04). To place this in a context, albeit speculative, we note that studies 
on mouse models of traumatic brain injury have shown a 60% reduction of 
glymphatic pathway post-injury, most pronounced 3 to 7 days and persisting at least a 
month, the effect likely mediated through altered localization of the astroglial water 
channel aquaporin-4 (7). Thus mild neuronal injury divers during STA may have 
caused impaired clearance of T-tau during the subsequent competitions. However, 
this line of thought is not entirely consistent with recent findings on ice hockey 
players who suffered concussion, and where T-tau was increased within 1 hour of 
injury, followed by an initial decline during the first 12 hours and then a trend 
towards a secondary increase peaking at about 36 hours (20). 
 
The third finding was that neither NFL nor S-100β showed any change in 
concentration or correlation to apneic time. This may be due to a different distribution 
pattern of these biomarkers in the brain. NFL is predominately expressed in 
subcortical myelinated axons while S-100β is predominately expressed in astrocytes 
(6, 19). Theoretically, this could render NFL and S-100 more resilient to a transient 
hypoxic state. 
 
The main limitation of this study was the small sample size, which restricts the 
generalizability of the results. We also did not directly measure SaO2, and thus we 
cannot be certain if the level of hypoxia correlated to apneic time, in particular during 
the dynamic events.  
 
Conclusion 
In conclusion, transient hypoxia may acutely increase levels of Aβ42 and T-tau in 
healthy adults thus further supporting that general hypoxia may stimulate Aβ 
production, with potential implications in AD molecular pathogenesis, and cause mild 
transitory neuronal dysfunction or damage. 
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FIGURES 
 
Fig. 1. Biomarkers for structural brain injury and amyloid metabolism amongst 
divers across all events, median value and interquartile range. Plasma T-tau, serum 
NFL and plasma Aβ42 measured in pg/mL (left Y-axis), serum S-100β measured in 
µg/L (right Y-axis). Significant elevations were seen at STA compared to baseline 
regarding Aβ42 (p = 0.006) and T-tau (p = 0.001). 
  
Fig. 2. Linear regression and 95% confidence bands of biomarker levels vs. apneic 
time. A-C, No significant correlation of apneic time with Aβ42, NFL or S-100β 
concentrations. D, Apneic time correlated to levels of T-tau at STA (ρ = 0.72, p = 
0.004) and during DYN1 (ρ = 0.66, p = 0.01).  
 
 
TABLES 
 
Table 1. Demographics and descriptive statistics of blood biomarkers and apneic time 
at baseline and across competitions 
Median (Range) [n] 
 Baseline STA DYN1 DYN2 
Measurement Controls Divers 
Age, years 32 (27-38) [5] 36 (16-51) [16] 
 
Sex, M/F 4/1 [5] 14/2 [16] 
Aβ42, pg/mL 11.9 (5.07-
20.2) [5] 
8.16 (0.62-
12.0) [16] 
11.3 (0.57-
16.6) [15] 
7.45 (0.32-
15.7) [13] 
8.21 (0.92-
14.8) [14] 
T-tau, pg/mL 0.007 (0.007-
0.007) [5] 
0.128 
(0.007-
0.253) [16] 
0.251 
(0.007-2.57)  
[15] 
0.112 
(0.007-
2.37) [14] 
0.069 
(0.007-
2.00) [14] 
S-100β, µg/L 0.04 (0.03-
0.08) [5] 
0.04 (0.02-
0.08) [16] 
0.050 (0.03-
0.09) [15] 
0.045 (0.03-
0.09) [14] 
0.04 (0.03-
0.16) [14] 
NFL, pg/mL 5.8 (2.21-
9.08) [5] 
7.03 (2.42-
14.7) [16] 
7.11 (3.72-
14.3) [15] 
6.98 (3.15-
21.6) [14] 
6.66 (2.85-
12.6) [14] 
Apneic time, 
minutes 
- - 5.03 (2.30 – 
7.63) [15] 
1.83 (1.08 – 
2.67) [16] 
1.78 (1.13 – 
2.83) [14] 
 
 
REFERENCES 
 
1. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van 
Nostrand W, Miano JM, and Zlokovic BV. SRF and myocardin regulate LRP-mediated amyloid-
beta clearance in brain vascular cells. Nature cell biology 11: 143-153, 2009. 
2. Blackwell T, Yaffe K, Laffan A, Redline S, Ancoli-Israel S, Ensrud KE, Song Y, Stone 
KL, and Osteoporotic Fractures in Men Study G. Associations between sleep-disordered breathing, 
nocturnal hypoxemia, and subsequent cognitive decline in older community-dwelling men: the 
osteoporotic fractures in men sleep study. J Am Geriatr Soc 63: 453-461, 2015. 
3. Blennow K, de Leon MJ, and Zetterberg H. Alzheimer's disease. Lancet 368: 387-403, 
2006. 
4. Craig AB, Jr., and Medd WL. Oxygen consumption and carbon dioxide production during 
breath-hold diving. J Appl Physiol 24: 190-202, 1968. 
5. Ferretti G, Costa M, Ferrigno M, Grassi B, Marconi C, Lundgren CE, and Cerretelli P. 
Alveolar gas composition and exchange during deep breath-hold diving and dry breath holds in elite 
divers. Journal of applied physiology 70: 794-802, 1991. 
6. Friede RL, and Samorajski T. Axon caliber related to neurofilaments and microtubules in 
sciatic nerve fibers of rats and mice. The Anatomical record 167: 379-387, 1970. 
7. Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, Singh I, Deane R, and 
Nedergaard M. Impairment of glymphatic pathway function promotes tau pathology after traumatic 
brain injury. J Neurosci 34: 16180-16193, 2014. 
8. Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, 
Schelosky L, Cervos-Navarro J, and DeArmond SJ. Ischemic stress induces deposition of amyloid 
beta immunoreactivity in human brain. Acta neuropathologica 90: 461-466, 1995. 
9. Jessen NA, Munk AS, Lundgaard I, and Nedergaard M. The Glymphatic System: A 
Beginner's Guide. Neurochem Res 2015. 
10. Kalaria RN, and Ballard C. Overlap between pathology of Alzheimer disease and vascular 
dementia. Alzheimer disease and associated disorders 13 Suppl 3: S115-123, 1999. 
11. Mondello S, Buki A, Barzo P, Randall J, Provuncher G, Hanlon D, Wilson D, Kobeissy 
F, and Jeromin A. CSF and plasma amyloid-beta temporal profiles and relationships with 
neurological status and mortality after severe traumatic brain injury. Sci Rep 4: 6446, 2014. 
12. Neselius S, Zetterberg H, Blennow K, Randall J, Wilson D, Marcusson J, and Brisby H. 
Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma. Brain injury : 
[BI] 27: 425-433, 2013. 
13. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, and Iadecola C. A beta-
peptides enhance vasoconstriction in cerebral circulation. American journal of physiology Heart and 
circulatory physiology 281: H2417-2424, 2001. 
14. Osorio RS, Gumb T, Pirraglia E, Varga AW, Lu SE, Lim J, Wohlleber ME, Ducca EL, 
Koushyk V, Glodzik L, Mosconi L, Ayappa I, Rapoport DM, de Leon MJ, and Alzheimer's 
Disease Neuroimaging I. Sleep-disordered breathing advances cognitive decline in the elderly. 
Neurology 2015. 
15. Qi JP, Wu H, Yang Y, Wang DD, Chen YX, Gu YH, and Liu T. Cerebral ischemia and 
Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. 
Journal of Alzheimer's disease : JAD 12: 335-341, 2007. 
16. Qiu C, Winblad B, and Fratiglioni L. The age-dependent relation of blood pressure to 
cognitive function and dementia. The Lancet Neurology 4: 487-499, 2005. 
17. Randall J, Mortberg E, Provuncher GK, Fournier DR, Duffy DC, Rubertsson S, 
Blennow K, Zetterberg H, and Wilson DH. Tau proteins in serum predict neurological outcome after 
hypoxic brain injury from cardiac arrest: Results of a pilot study. Resuscitation 2012. 
18. Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, 
Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, and Duffy DC. Single-
molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar 
concentrations. Nature biotechnology 28: 595-599, 2010. 
19. Shahim P, Mansson JE, Darin N, Zetterberg H, and Mattsson N. Cerebrospinal fluid 
biomarkers in neurological diseases in children. European journal of paediatric neurology : EJPN : 
official journal of the European Paediatric Neurology Society 17: 7-13, 2013. 
20. Shahim P, Tegner Y, Wilson DH, Randall J, Skillback T, Pazooki D, Kallberg B, 
Blennow K, and Zetterberg H. Blood biomarkers for brain injury in concussed professional ice 
hockey players. JAMA Neurol 71: 684-692, 2014. 
21. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, and Song W. 
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. 
Proceedings of the National Academy of Sciences of the United States of America 103: 18727-18732, 
2006. 
22. Thomas T, Thomas G, McLendon C, Sutton T, and Mullan M. beta-Amyloid-mediated 
vasoactivity and vascular endothelial damage. Nature 380: 168-171, 1996. 
23. Trojanowski JQ, Schuck T, Schmidt ML, and Lee VM. Distribution of tau proteins in the 
normal human central and peripheral nervous system. The journal of histochemistry and cytochemistry 
: official journal of the Histochemistry Society 37: 209-215, 1989. 
24. Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, Ancoli-Israel S, and 
Stone KL. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in 
older women. JAMA 306: 613-619, 2011. 
25. Zetterberg H, Mortberg E, Song L, Chang L, Provuncher GK, Patel PP, Ferrell E, 
Fournier DR, Kan CW, Campbell TG, Meyer R, Rivnak AJ, Pink BA, Minnehan KA, Piech T, 
Rissin DM, Duffy DC, Rubertsson S, Wilson DH, and Blennow K. Hypoxia due to cardiac arrest 
induces a time-dependent increase in serum amyloid beta levels in humans. PLoS One 6: e28263, 2011. 
 
